OCS — Oculis Holding AG stock price, charts and financials

QT23Oculis Holding AG

Oculis Holding AG (NASDAQ: OCS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
12.72
+0.04+0.30%
OverviewShort InterestFilings
OCSQT23Oculis Holding AG·NASDAQ
12.72+0.30%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 2026S-8Registration of employee benefit securities
Aug 06, 20266-KForeign issuer report
Jun 25, 20266-KForeign issuer report
Jun 01, 20266-KForeign issuer report
May 14, 20266-KForeign issuer report
May 11, 20266-KForeign issuer report
Apr 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 21, 20266-KForeign issuer report
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 04, 202620-FAnnual report (foreign issuers)
Mar 04, 20266-KForeign issuer report
Mar 04, 2026F-3ASRF-3ASR
Mar 03, 20266-KForeign issuer report
Dec 08, 2025EFFECTNotice of effectiveness
Dec 05, 2025POS AMPost-effective amendment
Dec 01, 2025424B3Prospectus
Nov 14, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Nov 10, 2025F-3F-3
Nov 10, 20256-KForeign issuer report
Oct 31, 20256-KForeign issuer report
Oct 31, 2025424B5Prospectus
Oct 31, 2025424B5Prospectus
Oct 29, 20256-KForeign issuer report
Oct 06, 20256-KForeign issuer report
Aug 21, 20256-KForeign issuer report
#1 / 25 of 105
Page
▼
/ 5